On Friday, July 22, 2011, the United Nations Environment Programme (UNEP) distributed a revised text for its comprehensive global treaty on mercury. Advocates for mercury-free drugs were gratified to see pharmaceuticals listed in "Annex C (Mercury-added product not allowed)" of the proposed treaty.
In February 2009, the Governing Council of UNEP
agreed on the need to develop a global legally binding instrument on mercury. The work to prepare this instrument is undertaken by an intergovernmental negotiating committee supported by the Chemicals Branch of the UNEP Division of Technology, Industry and Economics as secretariat.
It is planned that the work of the intergovernmental negotiating committee will be carried out over five sessions:
- INC 1: 7 to 11 June 2010, Stockholm, Sweden
- INC 2: 24 to 28 January 2011, Chiba, Japan
- INC 3: 31 October to 4 November 2011, Nairobi
- INC 4: June 2012 (to be confirmed)
- INC 5: early 2013 (to be confirmed)
Mercury compounds, such as Thimerosal (49.6% mercury by weight), are still used as a vaccine preservative
and in-process sterilizing agent, and are an unnecessary, and sometimes
undisclosed, component in many vaccines. Its use is associated with neurodevelopmental disorders
, birth defects
. Those most vulnerable to the toxic effects of Thimerosal in vaccines are the unborn and newborn
As a reaction to the discussion during INC2 in Chiba, UNEP distributed a revised text for its comprehensive global treaty on mercury now also mentioning pharmaceuticals.UNEP's revised text for its comprehensive global treaty on mercury
The Coalition for Mercury-free Drugs (CoMeD)
helped initiate this addition through its
advocacy efforts at the United Nations (UN) negotiations held in Chiba,
n, in January 2011. CoMeD President Rev. Lisa Sykes, the mother of
a son diagnosed with vaccine-related mercury poisoning, described to
representatives of over 150 participating nations
how: "... unnecessarily injecting mercury into
pregnant women and children, as part of a vaccine or other drug, is an
ongoing and often unrecognized crisis."
Addressing the diplomats attending the UN meeting in Chiba, Dr. Mark R.
Geier of CoMeD observed
: "For this treaty to be fully effective, it must make
clear that the intentional exposure of humans, especially pregnant women and
young children, to mercury, will not be tolerated."
Dr. Geier's comments were especially well-received by the diplomats from
developing nations. CoMeD representatives met with regional working groups
in closed-door sessions and explained the feasibility of using
2-phenoxyethanol, a much less toxic alternative to Thimerosal, in vaccines and other
Dr. Geier challenged the inequity of providing wealthy nations with
vaccines having reduced levels of mercury while poor nations still receive
vaccines containing dangerously high levels of mercury: "Children around the world, no matter their place of birth or their
income level, deserve safe mercury-free vaccines. The practice of providing
mercury-reduced and mercury-free vaccines to developed countries while
insisting that developing nations take mercury-containing ones is wrong."
By the end of negotiations in Chiba, diplomats from developing countries
requested the Secretariat to assess the safety of mercury in drugs.
A team of scientists and advocates from CoMeD will attend the next
treaty negotiation in Nairobi, Kenya, from October 31 through November 4,
2011, to support keeping this global ban on mercury-containing
drugs in the finalized UN treaty.
Source: Adapted from CoMeD
UNEP: Reducing Risk from Mercury
UNEP: Mercury publications
UNEP: New draft text for a comprehensive and suitable approach to a global legally binding instrument on mercury
FDA: Thimerosal in vaccines
CDC: Thimerosal in Vaccines: A Joint Statement of the American Academy of Pediatrics and the Public Health Service
Coalition for Mercury-free Drugs (CoMeD): Calls for Ban on Mercury in Vaccines
Coalition for Mercury-free Drugs (CoMeD): Documents related to the use of thimerosal in vccines
Coalition for Mercury-free Drugs (CoMeD): The Viability of Using Non-mercury Preservatives in Vaccines
Vaccination News, March 14, 2011: Thimerosal Containing Vaccines, Part I
House of Representatives' 2003 report: Mercury in Medicine - Taking
Unnecessary Risks (the result of a 3-year investigation)
Related EVISA Resources
EVISA Link database: Industrial use of mercury and its compounds
EVISA Link database: Toxicity of inorganic mercury compounds
EVISA Link database: Toxicity of organic mercury compounds
EVISA Link database: All about thimerosal (thiomersal)
Related EVISA News
EVISA News, June 19, 2011: Committee for Socio-economic Analysis agrees on two draft opinions on restriction proposals for mercury compounds under REACH
EVISA News, March 17, 2011: Researchers Urge the Removal of Mercury From Flu Shots
News, September 25, 2010: The European Chemical Agency (ECHA) calls for
comments on reports proposing restrictions on mercury and phenylmercury
EVISA News, August 16, 2010: Methylmercury: What have we learned from Minamata Bay?
EVISA News, September 24, 2009: Huge field experiment for assessing human ethylmercury risk starting in october
EVISA News, July 15, 2009: New Study Finds: Thimerosal Induces Autism-like Neurotoxicity
EVISA News, May 15, 2008: New study will investigate the influence of environmental factors in autism
EVISA News, May 3, 2006: Texas Study Relates Autism to Environmental Mercury
last time modified: August, 9, 2011